The DOI matches its Crossref record; 121 of the 123 references it cites were found in a registry or an index.
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Open accessAbstract
The gut microbiota alters energy homeostasis. In parallel, metformin regulates upper small intestinal sodium glucose cotransporter-1 (SGLT1), but whether changes of the microbiota or SGLT1-dependent pathways in the upper small intestine mediate metformin action is unknown. Here we report that upper small intestinal glucose sensing triggers an SGLT1-dependent pathway to lower glucose production in rodents. High-fat diet (HFD) feeding reduces glucose sensing and SGLT1 expression in the upper small intestine. Upper small intestinal metformin treatment restores SGLT1 expression and glucose sensing while shifting the upper small intestinal microbiota partly by increasing the abundance of Lactobacillus. Transplantation of upper small intestinal microbiota from metformin-treated HFD rats to the upper small intestine of untreated HFD rats also increases the upper small intestinal abundance of Lactobacillus and glucose sensing via an upregulation of SGLT1 expression. Thus, we demonstrate that metformin alters upper small intestinal microbiota and impacts a glucose-SGLT1-sensing glucoregulatory pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“animal studies revealed that metformin’s glucoregulatory role was an effect of increased Lactobacilli abundance in the upper small intestine, while its anti-inflammatory role was associated with increased abundance of Akkermansia, Bacteroides, Butyricimonas, and Parabacteroides genera”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Bauer et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058
Cited by
Sorted by citations
Items 201–266 of 266
Lopez‐Pier, M. A., Koppinger, M. P., Harris, P. R., Cannon, D. K., Skaria, R. S., Hurwitz, B. L., Watts, G. S., Aras, S. G., Slepian, M. J., & Konhilas, J. P. (2021) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2021.106302 · Cited by 5
Soetoko, A. S., Cahyaningrum, D., Ardiansyah, F., & Fatmawati, D. S. (2023) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v7i2.19 · Cited by 5
Dumitru, C. N., Dumitru, A. O., Goroftei, L., Niculet, E., Ignat, M. D., Baroiu, L., Nechita, A., & Balan, G. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060651 · Cited by 4
Mapping the current research landscape of metformin in cancer based on bibliometric analysis
Wang, Y., He, S., Li, Z., Jiang, N., & Sun, G. (2025) · Discover Oncology · doi:10.1007/s12672-025-03327-z · Cited by 4
Chen, R., Wei, W., Li, L., Zhang, M., Wang, N., Ge, R., Shen, Y. L., Zhang, W., Lu, D., Liao, W., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501689r · Cited by 4
Zhang, M., Feng, R., Yue, J., Cheng, Q., Yang, M., Liu, W., Rayner, C. K., & Ma, J. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1135-9031 · Cited by 4
Bi, R., Gao, J., Pan, L., & Lai, X. (2020) · Natural Product Communications · doi:10.1177/1934578x20918418 · Cited by 4
Schweighofer, N., Genser, B., Maerz, W., Kleber, M. E., Trummer, O., Pieber, T. R., & Obermayer-Pietsch, B. M. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s235663 · Cited by 4
Advances in Intestinal Glucose Absorption Regulation for Ruminant Energy Efficiency Improvement
Yan, Y., Zhang, X., Yao, J., & Lei, X. J. (2026) · Animals · doi:10.3390/ani16040659 · Cited by 4
Gut microbiome disparities reflect type 2 diabetes progression and medication status
Kumar, M., Singh, S., Ojha, R., Kriti, M., Park, G., Verma, V., Pal, N., Sharma, P., Shubham, S., Pandey, M. K., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115156 · Cited by 3
Metformin Boosts Intestinal Lipid Sensing via GIP to Suppress Feeding
Kuah, R., Wang, M. T., Yang, Z., Back, G., Li, R., Bruce, K., LoChoy, J. N., Beaudry, J. L., Barros, D. R., Zhang, S., et al. (2025) · Diabetes · doi:10.2337/db25-0100 · Cited by 5
Self-citationDonnées récentes sur le mécanisme d’action de la metformine dans le diabète de type 2
Foretz, M., Guigas, B., & Viollet, B. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.09.005 · Cited by 3
Metformin, Microbiota and Health
Paz, G. S., & Fernandes, J. (2022) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2022.00032 · Cited by 3
Buğdaycı, A. Y., Dizakar, S. Ö. A., Demirel, M. A., Ömeroğlu, S., Akar, F., & Uludağ, M. O. (2024) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-024-00521-2 · Cited by 4
van Hoorn, E. G. M., van Dijk, P. R., Prins, J. R., Lutgers, H. L., Hoogenberg, K., Erwich, J. J., & Kooy, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056282 · Cited by 3
Per, B. L., Loeser, S., Edwards, S., Lee, W. S., Wilton, L. R., & Clark, S. R. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13796 · Cited by 3
Mechanisms of efficacy of drug therapy in type 2 diabetes: the role of microbiomes
Li, Y., Ziling, H. E., Li, C., Huang, J., & Zheng, Y. U. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.25.04306-4 · Cited by 2
Anti-diabetic medications and cancer: links beyond glycemic and body weight control
Cao, M., Lin, C., Cai, X., Lv, F., Yang, W., & Ji, L. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf028 · Cited by 2
Metformin and Myo-Inositol: A Comparative Analysis
Russo, M., Oliva, M. M., Nordio, M., Porcaro, G., & Unfer, V. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000549646 · Cited by 3
Fluoride-induced gut dysbiosis in metabolic disorders: Mechanisms and public health implications
Meenakshi, S., Amrutha, T. V., Abubakar, M., Prakash, V., Kumar, N., & Murti, K. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127806 · Cited by 2
Metformin in prediabetes: key mechanisms for the prevention of diabetes and cardiometabolic risks
Babenko, A. Y. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-10-96-103 · Cited by 2
Managing Glucose Homeostasis Through the Gut Microbiome
Weninger, S. N., Manley, A., & Duca, F. A. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-051524-094728 · Cited by 3
Self-citationCritical Thinking about Literature through Computer Networking.
Long, T. L., & Pedersen, C. (1992) · Cited by 2
Interaction between the gut microbiota and oral antihyperglycemic drugs
Buyvalenko, U. V., & Pokrovskaya, E. V. (2022) · Problems of Endocrinology · doi:10.14341/probl12835 · Cited by 2
Wang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., Xie, Z., Chu, X., Yang, J., Wang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0377-7 · Cited by 2
Anti‐Diabetic Intestinal Mechanisms: Foods, Herbs, and Western Medicines
Feng, Y., Cao, H., Hua, J., & Zhang, F. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200106 · Cited by 2
Elkrinawi, J., Ganayem, R., Weissmann, S., Alamour, W., Lerner, Z., Alamour, O., Ganim, A. A., & Abu‐Freha, N. (2025) · Colorectal Disease · doi:10.1111/codi.70185 · Cited by 1
Li, Y., Xingqi, G., Dong, X., Xia, T., Ma, S., & Liu, Z. (2026) · iScience · doi:10.1016/j.isci.2026.114877 · Cited by 1
Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome–drug–host triad
Strilić, D., Stanimirov, B., Pavlović, N., Lazarević, S., Mikov, M., Stanivukovic, T., & Đanić, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1831882 · Cited by 1
Metformin and intestinal microbiota
Григорьева, И. Н., Романова, Т. И., Станиславовна, С. Т., & Nepomnyashchikh, D. L. (2024) · Medical alphabet · doi:10.33667/2078-5631-2024-26-19-23 · Cited by 1
Kumar, V., Enes, P., Singha, K. P., Esmaeili, N., Soengas, J. L., & Panserat, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90873-3.00008-7 · Cited by 1
Silencing gut CCK cells alters gut reaction to sugar
Yue, J. T. Y., Duca, F. A., & Lam, T. K. T. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00998-z · Cited by 1
Self-citationShoemaker, A. H. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1228
Beauchemin, E. T. (2018) · UA Campus Repository (The University of Arizona)
Liu, Q., Liu, S., Cao, H., Ji, W., Li, C., Huan, Y., Lei, L., Fu, Y., Liu, Y., & Shen, Z. (2020) · Research Square · doi:10.21203/rs.3.rs-122185/v1
Capsaicin Improves The Hypoglycemic Effect of Metformin Benefitted From Gut MicrobiotaPreprint
Kang, Z., Hu, J., Chen, M., Mao, Y., Xie, L., Yang, N., Liu, T., Zhang, W., & Huang, W. (2021) · Research Square · doi:10.21203/rs.3.rs-882559/v1
Zaccaria, E., Klaassen, T., Alleleyn, A. M. E., Boekhorst, J., Smokvina, T., Kleerebezem, M., & Troost, F. J. (2021) · Research Square · doi:10.21203/rs.3.rs-1196536/v1
Crawford, J. M., & Goddard, T. N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736512366.793566892
Chao, N. J. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736512366.793568917
Han, J. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736512366.793573403
Study on Diabetic Rats Comparing the Effects of Sitagliptin and Probiotics on Serum Glucose
Lateef, N., Rehman, I., Tahir, M., Tahir, M. N., ., A., & Memon, F. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221651135
Wang, X., Wu, J., Qi, S., Huang, R., Wu, X., Tian, L., Wang, P., & Wang, S. (2021) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20210604.15
The energy-rush and insulin model of obesity
Jia, H. (2023) · Research Ideas and Outcomes · doi:10.3897/rio.9.e108748
Mechanistic Insights of Dietary Modulation on Gut Microflora and Associated Physiological Changes
Yadav, A., Hamsa, S., Tiwari, R., Bharti, A., Dhewa, T., Mehrotra, R., & Verma, P. (2023) · Wiley eBooks · doi:10.1002/9781394229116.ch3
Hieshima, K., Sugiyama, S., Yoshida, A., Kurinami, N., Suzuki, T., MIYAMOTO, F., Kajiwara, K., Jinnouchi, K., Jinnouchi, T., & Jinnouchi, H. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3982-24 · Cited by 1
Rao, M. V., Messina, J. A., & Surana, N. K. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0017
Microbiota intestinale e farmaci ipoglicemizzanti: la comunicazione che cura
Rubino, M., Cassano, V., & Hribal, M. L. (2025) · il Diabete · doi:10.30682/ildia2501c
Novel Therapies: Pharmacological Approaches to Modulate the Gut Microbiome in Metabolic Syndrome
Gunjan, & Vidić, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_5
Zaccaria, E., Klaassen, T., Alleleyn, A. M. E., Boekhorst, J., Smokvina, T., Kleerebezem, M., & Troost, F. J. (2023) · Figshare · doi:10.6084/m9.figshare.22617536
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584009
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584012
Zaccaria, E., Klaassen, T., Alleleyn, A. M. E., Boekhorst, J., Smokvina, T., Kleerebezem, M., & Troost, F. J. (2023) · Figshare · doi:10.6084/m9.figshare.22617545
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584006
Weninger, S. N., Herman, C., Meyer, R. K., Beauchemin, E. T., Kangath, A., Lane, A. I., Martinez, T. M., Hasneen, T., Jaramillo, S. A., Lindsey, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26608063
Self-citationZhu, X., Shen, J., Feng, S., Huang, C., Wang, H., Huo, F., & Liu, H. (2023) · Figshare · doi:10.6084/m9.figshare.23265023
Carrizales-Sánchez, A. K., Tamez‐Rivera, O., Rodríguez-Gutiérrez, N. A., Elizondo‐Montemayor, L., Gradilla-Hernández, M. S., García-Rivas, G., Pacheco, A., & Senés‐Guerrero, C. (2023) · Figshare · doi:10.6084/m9.figshare.22757257
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584003
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
Shan, K., Li, Q., Liu, H. Y., Feng, N., Jiang, S., Zhao, D., Ke, W., Zhang, M., & Li, C. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.03.018
The gut microbiota-diabetes axis: mechanisms, modulation, and therapeutic perspectives
Bora, J., Lata, S., Kumari, A., Priya, S., Barman, I., Mondal, S., Dhasmana, A., Rustagi, S., Thapliyal, S., Deshwal, R. K., et al. (2026) · Biochimica Clinica · doi:10.23736/s0393-0564.26.00097-x
Exploring the competitive inhibition mechanism of α-glucosidase by metformin
Tian, M., Xiao, C., Wei, Y., Li, Y., Li, S., Li, S., Guo, H., Tuo, X., & Chi, B. H. C. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110106
Wilson, D. V., Acharjee, A., Duggal, N. A., Hombrebueno, J. R., Jones, S. W., Lewis, J. W., de Magalhães, J. P., Martínez-Serrato, Y., Mazaheri, A., McGettrick, H. M., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346347
Zeng, J., Zhou, L., Liao, L., Wu, D., Yang, R., Zhang, C., Bai, Z., Fan, X., Zhou, X., Zhang, C., et al. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07127-3
Fan, Z., Yu, Y., Dong, C., Bu, W., Yu, Y., Li, S., Wang, Z., & Bai, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117507
Loss of Intestinal MSTN Promotes GLP‐1 Secretion Through SGLT1 Palmitoylation
Han, S., Chang, S., Luo, Z., Sun, K., Quan, B., Lv, Y., Li, Z., Liu, X., Lv, S., Xuan, M., et al. (2026) · Advanced Science · doi:10.1002/advs.78302
Metadata
- Authors
- Bauer, P. V., Duca, F. A., Waise, T. M. Z., Rasmussen, B. A., Abraham, M. A., Dranse, H. J., Puri, A., O’Brien, C. A., & Lam, T. K. T.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Lam, Tony K.T.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 27
- Issue
- 1
- Pages
- 101-117.e5
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2765695466
- Cited by
- 265
- References
- 123
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 27 · 2023: 47 · 2022: 36 · 2021: 37 · 2020: 31 · 2019: 25 · 2018: 22
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (FDN-143204)
- Banting and Best Diabetes Centre, University of Toronto
- Diabetes Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, gut microbiota, upper small intestine, SGLT1, glucose detection, glucoregulation, glucose production, high-fat diet, Lactobacillus, microbiota transplantation, energy homeostasis
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Gastrointestinal Microbiome, Animals, Feeding Behavior, Glucose, Intestine, Small, Metformin, Principal Component Analysis, Sodium-Glucose Transporter 1, Rats, Glucagon-Like Peptide 1, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review